Sep. 11 at 5:40 PM
$UNCY CEO gave a lot of “ifs” and “when’s”. But no real key information regarding how close we are to FDA approval. Short term I’m not expecting much. At the end of the day, the only issue was the supplier which means a definite approval will come at some point. There just needs to be more transparency and updates to the investors. I’m about tired of it sitting at low 4s with the potential this stock has for approval in the near future. CEO needs to do better.
